Michael F. DeFranco currently serves as Chair of the Firm's Global M&A Practice Group. He advises clients on transactional matters, including mergers and acquisitions, securities law compliance, corporate governance issues and disclosure concerns. His extensive experience includes representing multinational companies in both public and private acquisitions and divestitures.
Mr. DeFranco concentrates on mergers and acquisitions, corporate finance as well as general corporate and securities matters. He represents buyers, sellers and their financial advisers in a wide variety of transactions — including negotiated and contested public and private acquisitions and divestitures, cross-border transactions (both inbound and outbound) and other strategic alliances. Mr. DeFranco also advises public companies on various governance and compliance issues.
Representative Legal Matters
Represented Servier in its acquisition of Shire's Oncology Business.
Represented FedEx Corporation in multiple transactions, including: (i) FedEx's acquisition of Genco Distribution System, Inc.; and (ii) FedEx's acquisition of TNT Express N.V.
Represented Safran S.A. in multiple transactions, including: (i) Safran's sale of its Morpho Detection business; (ii) Safran's acquisition of the Aerospace Power Distribution Management Solutions and Integrated Cockpit Solutions business of Eaton Corporation; (iii) Safran’s acquisition of Harvard Custom Manufacturing Inc.; and (iv) Safran’s sale of Cinch Connectors.
Represented Brunswick Corp. in its sale of its bowling products business and its acquisition of Cybex.
Represented the special committee of the board of directors of Telvent GIT S.A. in Schneider Electric’s tender offer to acquire 100 percent of the shares of Telvent.
Represented Abbott Laboratories in multiple transactions, including: (i) Abbott's acquisition of the pharmaceutical business of the Solvay Group; (ii) Abbott’s sale of Innogenetics NV; and (iii) Abbott's acquisition of TheraSense Inc.
Represented Hospira Inc. in its acquisition of the generic injectable pharmaceuticals business of Orchid Chemicals & Pharmaceuticals Ltd.
Represented Gas Natural SDG S.A. in multiple transactions, including: (i) Gas Natural's disposition of a minority stake in its operations in Argentina; (ii) Gas Natural's acquisition of assets in Mexico; and (iii) Gas Natural's attempted unsolicited acquisition of Endesa S.A.
Represented Mecalux S.A. in its acquisition of the racking business of UFC Interlake out of bankruptcy.
Represented Guidant Corporation in the attempted acquisition of Guidant by Johnson & Johnson.
- Illinois~United States (2002)
- New York~United States (1999)
- Columbia Law School (J.D. Harlan Fiske Stone Scholar) (1998)
- Yale University (M.A.) (1997)
- University of Notre Dame (B.A. summa cum laude) (1994)